Amulet Capital Partners
Amulet Capital Partners is a middle-market private equity firm specializing in leveraged buyouts, restructurings, growth equity and other equity-linked investments across a wide range of subsectors in the healthcare industry.
2024-07-30
Funding Date
31
Employees
United States
Location
New York, New York
City & State
Sales-Ready Summary
Amulet Capital recently received funding, and their tech stack includes various JavaScript libraries and WordPress plugins, making them a potential prospect for vendors offering tools and services in these areas.
Key Contacts
Open Positions
View Careers PageSimilar Startups
Quanta
Quanta provides software companies with real-time financial clarity and empowerment. Quanta envision a world in which all business accounting tasks that are not creative in nature are automated, leaving finance teams and business owners to focus solely on strategic and creative work.
Amnis
Amnis offers services such as currency exchange, international payments, and flexible currency hedging, enabling small and medium-sized companies to strategize and execute their international payments digitally.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.